N4 PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.715 GBX | +14.40% |
|
-10.62% | -15.88% |
| 04-25 | N4 Pharma strikes partnership deal for intracellular delivery | AN |
| 04-23 | N4 Pharma loss widens but "great optimism" remains | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.45M | - | - | - | - | - | |
| 727B | ||||||
| 599B | ||||||
| 354B | ||||||
| 328B | ||||||
| 277B |
- Stock Market
- Equities
- ONZ Stock
- Charts N4 Pharma Plc
- Sector Chart
